Combating breast cancer-associated metastasis using paclitaxel and tranilast-loaded human serum albumin nanoparticles

HSA nanoparticles enhance the delivery and accumulation of hydrophobic drugs (PTX and TRA) in breast cancer cells, offering improved therapeutic outcomes. This combinatorial strategy permits further preclinical investigation for synergistic breast cancer management.